InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Tuesday, 09/21/2021 1:22:41 PM

Tuesday, September 21, 2021 1:22:41 PM

Post# of 14947
2022 will be a great year for Sorrento. Why?
Two programs. Abivertinib(cancer) and SP-102(pain).
Both will be multi-Billion dollar sales programs!
But what about the Covid programs?
Covi-Stix has received its first EUA and sales will soon be reported.
Covid is not going away...Covi-AMG, Covi-Drops, Abivertinib(ARDS), Covi-MSC and the anti-virals and second generation vaccines will be needed.
Sorrento's connections with DARPA and the NAVY will pay off.
Aircraft carriers and submarines cannot afford Covid outbreaks.
Sorrento has the worlds largest anti-Covid portfolio. It will be needed and I look forward to worldwide marketing partnerships being announced.
All the best to all the longs!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News